In conclusion, our results suggest PDK1 is overexpressed in RB and tumor growth could be attenuated by DCA treatment via inhibition of PI3K/Akt pathway and decrease in PDK1 protein levels. This evidence concerns the gene PDK1 and retinoblastoma.